Antimicrobial resistance surveillance system mapping in different countries

Ramendra Pati Pandey; Riya Mukherjee; Chung-Ming Chang

doi:10.33393/dti.2022.2482

Authors

Ramendra Pati Pandey Centre for Drug Design Discovery and Development (C4D), SRM University, Sonepat, Haryana - India https://orcid.org/0000-0002-5196-6468
Riya Mukherjee Master & PhD program in Biotechnology Industry, Chang Gung University, Taoyuan City and Graduate Institute of Biomedical Sciences, Department of Biotechnology, Chang Gung University, Taoyuan City - Taiwan (R.O.C.)
Chung-Ming Chang Master & PhD program in Biotechnology Industry, Chang Gung University, Taoyuan City - Taiwan (R.O.C.)

DOI:

https://doi.org/10.33393/dti.2022.2482

Keywords:

Alternative Antibiotics, AMR, Comparative Medicine, One Health Approach, Phage Therapy, Surveillance

Abstract

Objectives: Excessive use of antibiotics has increased antimicrobial resistance (AMR) worldwide, which is a major public concern among the countries. To control this threat proper monitoring of the antimicrobial usage with increasing rate of AMR is required. Moreover, alternatives for antibiotics are surveyed and are being researched for quick use in the future. Thus, multisector intervention is highly encouraged for better outcomes. In this research article, six different European countries are discussed in terms of antimicrobial usage and AMR in human and livestock sectors with the help of literature study and various reports published by different organizations.

Methods. Data study has been conducted to collect data for comparison study. Data sources of AMR and antimicrobial usage are analyzed and both antimicrobial use and AMR are compared.

Results: This article provides surveillance systems that are formed to keep a track on the upcoming situation of AMR and the consumption of antimicrobials by humans as well as animals. The article firmly allows the readers to get broad information about the AMR across six countries of Europe. These annual reports have hugely helped the government to decide for alternatives and have focused in many training activities to combat the AMR situation globally.

Conclusion: As antibiotic resistance genes persist on an interface between environment and animal and animal health, an approach is required in all three areas that stress the concept of “One Approach to Health.”

Downloads

Download data is not yet available.

References

Mesa Varona O, Chaintarli K, Muller-Pebody B, et al. Monitoring Antimicrobial Resistance and Drug Usage in the Human and Livestock Sector and Foodborne Antimicrobial Resistance in Six European Countries. Infect Drug Resist. 2020;13:957-993. https://doi.org/10.2147/IDR.S237038PMID:32308439 DOI: https://doi.org/10.2147/IDR.S237038

Ionescu GF, Firoiu D, Pîrvu R, et al. The potential for innovation and entrepreneurship in EU Countries in the context of sustainable development. Sustainability (Basel). 2020;12(18):7250. https://doi.org/10.3390/su12187250 DOI: https://doi.org/10.3390/su12187250

Sikkema R, Koopmans M. One Health training and research activities in Western Europe. Infect Ecol Epidemiol. 2016;6(1):33703. https://doi.org/10.3402/iee.v6.33703 PMID:27906121 DOI: https://doi.org/10.3402/iee.v6.33703

Antibiotic use is rapidly increasing in developing countries. The Lancet 2018; Online https://www.economist.com/graphic-detail/2018/04/02/antibiotic-use-is-rapidly-increasing-in-developing-countries (Accessed August 2022)

The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2017/2018. 2020. Online https://www.efsa.europa.eu/en/efsajournal/pub/6007 (Accessed August 2022)

Schrijver R, Stijntjes M, Rodríguez-Baño J, Tacconelli E, Babu Rajendran N, Voss A. Review of antimicrobial resistance surveillance programmes in livestock and meat in EU with focus on humans. Clin Microbiol Infect. 2018;24(6):577-590. https://doi.org/10.1016/j.cmi.2017.09.013PMID:28970159 DOI: https://doi.org/10.1016/j.cmi.2017.09.013

RESAPATH. French surveillance network for antimicrobial resistance in bacteria from diseased animals. 2017 Annual Report . March 2019. Online https://www.anses.fr/en/system/files/LABO-Ra-Resapath2017EN.pdf (Accessed August 2022)

NIPH. Norwegian Institute of Public Health. Antibiotic resistance in Norway. 2014, updated 2018. Online https://www.fhi.no/en/id/antimicrobial/. (Accessed August 2022)

NIPH. Norwegian Institute of Public Health. NORM og NORM-VET: Usage of Antimicrobial Agents and Occurrence of Antimicrobial Resistance in Norway. Online: https://www.fhi.no/en/publ/2022/norm-og-norm-vet-usage-of-antimicrobial-agents-and-occurrence-of-antimicrob/ (Accessed August 2022)

National Institute for Public Health and the Environment. NethMap 2019. Consumption of antimicrobial agents and antimicrobial resistance among medically important bacteria in the Netherlands. Online: https://www.rivm.nl/bibliotheek/rapporten/2019-0038.pdf. (Accessed July, 2019)

Publication office of the European Union. 2013/652/EU: Commission Implementing Decision of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria (notified under document C(2013) 7145) Text with EEA relevance. Online https://op.europa.eu/en/publication-detail/-/publication/83e1934f-4d39-11e3-ae03-01aa75ed71a1 (Accessed August 2022)

European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net). Annual Epidemiological Report for 2019. Online https://www.ecdc.europa.eu/sites/default/files/documents/surveillance-antimicrobial-resistance-Europe-2019.pdf (Accessed August 2022)

Cassini A, Högberg LD, Plachouras D, et al; Burden of AMR Collaborative Group. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66. https://doi.org/10.1016/S1473-3099(18)30605-4PMID:30409683

WHO. 12th conference of HEPA Europe: “Implementing health-enhancing physical activity research: from science to policy and practice”:Online https://www.euro.who.int/en/health-topics/disease-prevention/antimicrobial-resistance/surveillance/central-asian-and-european-surveillance-of-antimicrobial-resistance-caesar. (Accessed August 2022)

Murray CJL, Ikuta KS, Sharara F, et al; Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-655. https://doi.org/10.1016/S0140-6736(21)02724-0 PMID:35065702 DOI: https://doi.org/10.1016/S0140-6736(21)02724-0

https://www.ecdc.europa.eu/en/news-events/who-and-ecdc-report-antimicrobial-resistance-remains-health-threat-europe. (Accessed August 2022)

Singhal T. Antimicrobial Resistance: The ‘Other’ Pandemic!: Based on 9th Dr. I. C. Verma Excellence Award for Young Pediatricians Delivered as Oration on 19th Sept. 2021. Indian J Pediatr. 2022;89(6):600-606. PMID:35064528 https://doi.org/10.1007/s12098-021-04008-9PMID:35064528 DOI: https://doi.org/10.1007/s12098-021-04008-9

Wu D, Ding Y, Yao K, Gao W, Wang Y. Antimicrobial Resistance Analysis of Clinical Escherichia coli Isolates in Neonatal Ward. Front Pediatr. 2021;9:670470. https://doi.org/10.3389/fped.2021.670470 PMID:34113589 DOI: https://doi.org/10.3389/fped.2021.670470

Chang S-M, Chen J-W, Tsai C-S, Ko W-C, Scaria J, Wang J-L. Antimicrobial-Resistant Escherichia coli Distribution and Whole-Genome Analysis of Sequence Type 131 Escherichia coli Isolates in Public Restrooms in Taiwan. Front Microbiol. 2022;13:864209. https://doi.org/10.3389/fmicb.2022.864209 PMID:35495726 DOI: https://doi.org/10.3389/fmicb.2022.864209

Health. IVSAISCO. Online: http://www.ivsa.org/standing-committees/one-health-2/scoh-projects/. (Accessed August 2022)

Singh S, Charani E, Devi S, et al. A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India. Antimicrob Resist Infect Control. 2021;10(1):32. PMID:33573697 https://doi.org/10.1186/s13756-020-00873-9PMID:33573697 DOI: https://doi.org/10.1186/s13756-020-00873-9

Ranjalkar J, Chandy SJ. India’s National Action Plan for antimicrobial resistance - An overview of the context, status, and way ahead. J Family Med Prim Care. 2019;8(6):1828-1834. PMID:31334140 https://doi.org/10.4103/jfmpc.jfmpc_275_19 PMID:31334140 DOI: https://doi.org/10.4103/jfmpc.jfmpc_275_19

Course. AOH. Online: http://antigonefp7.eu/young-antigone-2/2016-antigone-annual-one-health-course/, (Accessed August 2022)

Kumar M, Sarma DK, Shubham S, et al. Futuristic Non-antibiotic Therapies to Combat Antibiotic Resistance: A Review. Front Microbiol. 2021;12:609459. https://doi.org/10.3389/fmicb.2021.609459 PMID:33574807 DOI: https://doi.org/10.3389/fmicb.2021.609459

https://www.cdc.gov.tw/En/Category/ListContent/_P6IYUu810pMdu2FcTPp4g?uaid=BKM8MCw654j8jE0c1u4eEw

Wright RCT, Friman V-P, Smith MCM, Brockhurst MA. Resistance evolution against phage combinations depends on the timing and order of exposure. MBio. 2019;10(5):1652-e19. https://doi.org/10.1128/mBio.01652-19 PMID:31551330 DOI: https://doi.org/10.1128/mBio.01652-19

Vázquez R, García E, García P. Phage Lysins for Fighting Bacterial Respiratory Infections: A New Generation of Antimicrobials. Front Immunol. 2018;9:2252. https://doi.org/10.3389/fimmu.2018.02252 PMID:30459750 DOI: https://doi.org/10.3389/fimmu.2018.02252

Pursey E, Sünderhauf D, Gaze WH, Westra ER, van Houte S. CRISPR-Cas antimicrobials: challenges and future prospects. PLoS Pathog. 2018;14(6):e1006990. https://doi.org/10.1371/journal.ppat.1006990 PMID:29902258 DOI: https://doi.org/10.1371/journal.ppat.1006990

Marx C, Gardner S, Harman RM, Van de Walle GR. The mesenchymal stromal cell secretome impairs methicillin-resistant Staphylococcus aureus biofilms via cysteine protease activity in the equine model. Stem Cells Transl Med. 2020;9(7):746-757. https://doi.org/10.1002/sctm.19-0333PMID:32216094 DOI: https://doi.org/10.1002/sctm.19-0333

Costello SP, Hughes PA, Waters O, et al. Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial. JAMA. 2019;321(2):156-164. https://doi.org/10.1001/jama.2018.20046 PMID:30644982 DOI: https://doi.org/10.1001/jama.2018.20046

Vazquez-Munoz R, Lopez FD, Lopez-Ribot JL. Bismuth Nanoantibiotics Display Anticandidal Activity and Disrupt the Biofilm and Cell Morphology of the Emergent Pathogenic Yeast Candida auris. Antibiotics (Basel). 2020;9(8):E461. https://doi.org/10.3390/antibiotics9080461 PMID:32751405 DOI: https://doi.org/10.3390/antibiotics9080461

Schnall J, Rajkhowa A, Ikuta K, Rao P, Moore CE. Surveillance and monitoring of antimicrobial resistance: limitations and lessons from the GRAM project. BMC Med. 2019;17(1):176. https://doi.org/10.1186/s12916-019-1412-8 PMID:31537199 DOI: https://doi.org/10.1186/s12916-019-1412-8

Hay SI, Rao PC, Dolecek C, et al. Measuring and mapping the global burden of antimicrobial resistance. BMC Med. 2018;16(1):78. PMID:29860943 https://doi.org/10.1186/s12916-018-1073-z PMID:29860943 DOI: https://doi.org/10.1186/s12916-018-1073-z

World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System. (GLASS) report: early implementation 2017–2018. Online https://www.who.int/publications/i/item/9789241515061 (Accessed August 2022)